HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.

Abstract
The generation of functional regulatory T cells (Tregs) is essential to keep tissue homeostasis and restore healthy immune responses in many biological and inflammatory contexts. Cannabinoids have been pointed out as potential therapeutic tools for several diseases. Dendritic cells (DCs) express the endocannabinoid system, including the cannabinoid receptors CB1 and CB2. However, how cannabinoids might regulate functional properties of DCs is not completely understood. We uncover that the triggering of cannabinoid receptors promote human tolerogenic DCs that are able to prime functional FOXP3+ Tregs in the context of different inflammatory diseases. Mechanistically, cannabinoids imprint tolerogenicity in human DCs by inhibiting NF-κB, MAPK and mTOR signalling pathways while inducing AMPK and functional autophagy flux via CB1- and PPARα-mediated activation, which drives metabolic rewiring towards increased mitochondrial activity and oxidative phosphorylation. Cannabinoids exhibit in vivo protective and anti-inflammatory effects in LPS-induced sepsis and also promote the generation of FOXP3+ Tregs. In addition, immediate anaphylactic reactions are decreased in peanut allergic mice and the generation of allergen-specific FOXP3+ Tregs are promoted, demonstrating that these immunomodulatory effects take place in both type 1- and type 2-mediated inflammatory diseases. Our findings might open new avenues for novel cannabinoid-based interventions in different inflammatory and immune-mediated diseases.
AuthorsAlba Angelina, Mario Pérez-Diego, Jacobo López-Abente, Beate Rückert, Ivan Nombela, Mübeccel Akdis, Mar Martín-Fontecha, Cezmi Akdis, Oscar Palomares
JournalMucosal immunology (Mucosal Immunol) Vol. 15 Issue 1 Pg. 96-108 (01 2022) ISSN: 1935-3456 [Electronic] United States
PMID34548620 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021. The Author(s).
Chemical References
  • Anti-Inflammatory Agents
  • Cannabinoids
  • Indoles
  • Receptor, Cannabinoid, CB1
  • Receptor, Cannabinoid, CB2
  • Rimonabant
  • iodopravadoline
Topics
  • Anaphylaxis (prevention & control)
  • Animals
  • Anti-Inflammatory Agents
  • Autophagy
  • Cannabinoids (therapeutic use)
  • Cells, Cultured
  • Cellular Reprogramming
  • Coculture Techniques
  • Dendritic Cells (immunology, metabolism)
  • Humans
  • Hypersensitivity (drug therapy)
  • Immune Tolerance
  • Indoles (pharmacology)
  • Mice
  • Oxidative Phosphorylation
  • Receptor, Cannabinoid, CB1 (agonists, metabolism)
  • Receptor, Cannabinoid, CB2 (agonists, metabolism)
  • Rimonabant (pharmacology)
  • Signal Transduction
  • T-Lymphocytes, Regulatory (immunology)
  • Th1-Th2 Balance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: